A
$ Value
$0
Shares
25,873
Price
$0
Filed
Mar 4
Insider
Name
FRAZIER KENNETH C
Title
—
CIK
0001181175
Roles
Director
Transaction Details
Transaction Date
2026-03-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
25,873
Footnotes
1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.
Filing Info
Other Insiders at EIKN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Column Group IV GP, LP | $38.1M | — | 2026-02-06 |
| Lux Venture Partners V, LLC | $5.0M | — | 2026-02-06 |
| Wolfe Josh | $5.0M | — | 2026-02-06 |
| FRAZIER KENNETH C | $2.0M | — | 2026-02-04 |
| Foresite Capital Management IV, LLC | $1000K | — | 2026-02-04 |
|
PERLMUTTER ROGER M
See remarks
|
— | — | 2026-03-02 |
|
Baynes Roy D.
Chief Medical Officer
|
— | — | 2026-03-02 |
| Huffines Robert Luther | — | — | 2026-03-02 |
|
Klobuchar Michael A
Chief Operating Officer
|
— | — | 2026-03-02 |
|
Thorner Benjamin Bruno
See Remarks
|
— | — | 2026-03-02 |
|
Bowie Alfred Lloyd Jr.
Chief Financial Officer
|
— | — | 2026-03-02 |